New combo therapy shows promise for lung cancer brain tumors
NCT ID NCT04768075
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tested a drug called camrelizumab (an immunotherapy) plus chemotherapy and radiation for people with advanced lung cancer that had spread to the brain. 60 participants who had not received prior chemotherapy were randomly assigned to receive either the camrelizumab combination or a placebo combination. The goal was to see if the camrelizumab combo could better control brain tumor growth and extend time without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
Affiliated Hospital of Hebei University / School of Clinical Medicine
Baoding, Hebei, China
-
Affiliated Tumor Hospital of Guangxi Medical University
Nanning, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
-
Binzhou Medical University Hospital
Binzhou, Shandong, China
-
Fujian Cancer Hospital
Fujian, Fuzhou, China
-
Guangdong General Hospital
Guangzhou, Guangdong, 510080, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.